title: Failure of liver function tests in predicting drug clearance of chemotherapeutic agents in a patient who had recovered from hepatic congestion.
authors.forename: Masaharu
authors.initials: M
authors.lastname: Tsubokura
authors.forename: Yuji
authors.initials: Y
authors.lastname: Miura
authors.forename: Tatsuo
authors.initials: T
authors.lastname: Itokawa
authors.forename: Naoko
authors.initials: N
authors.lastname: Takei
authors.forename: Tadanao
authors.initials: T
authors.lastname: Higaki
authors.forename: Toshihiro
authors.initials: T
authors.lastname: Amaki
authors.forename: Yasuo
authors.initials: Y
authors.lastname: Ishida
authors.forename: Makiko
authors.initials: M
authors.lastname: Kusama
authors.forename: Shunsuke
authors.initials: S
authors.lastname: Ono
authors.forename: Hiroto
authors.initials: H
authors.lastname: Narimatsu
authors.forename: Masahiro
authors.initials: M
authors.lastname: Kami
authors.forename: Tsunehiko
authors.initials: T
authors.lastname: Komatsu
mesh_terms: D000369:Aged, 80 and over; D000410:Alanine Transaminase / Q000097:blood; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects*; D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects*; D001219:Aspartate Aminotransferases / Q000097:blood; D001663:Bilirubin / Q000097:blood; D015415:Biomarkers / Q000097:blood; D004317:Doxorubicin / Q000009:adverse effects*; D017809:Fatal Outcome; D006801:Humans; D008099:Liver / Q000473:pathology; D008107:Liver Diseases / Q000378:metabolism; D008111:Liver Function Tests / Q000592:standards*; D008223:Lymphoma / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008657:Metabolic Clearance Rate; D011237:Predictive Value of Tests; D014750:Vincristine / Q000009:adverse effects*
chemical_list: D000903:Antibiotics, Antineoplastic; D000972:Antineoplastic Agents, Phytogenic; D015415:Biomarkers; D014750:Vincristine; D004317:Doxorubicin; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D001663:Bilirubin